Ex Parte AXEL et al - Page 11


                Appeal No.  2001-0562                                                    Page 11                   
                Application No.  08/460,478                                                                        
                prior art applied is there a suggestion that would motivate one of ordinary skill in               
                the art to substitute adenoviral vectors for the herpes virus taught by Geller.                    
                       While a person of ordinary skill in the art may possess the requisite                       
                knowledge and ability to modify the protocol taught by the prior art, the                          
                modification is not obvious unless the prior art suggested the desirability of the                 
                modification.  In re Gordon, 733 F.2d 900, 902, 211 USPQ 1125, 1127 (Fed. Cir.                     
                1984).  On this record, we see no such reason to modify the references as                          
                applied.                                                                                           
                       With regard to the second criterion set forth in Dow, we are not persuaded                  
                by the examiner’s reliance on Stratford-Perricaudet and Cohen-Haguenauer for                       
                the teachings that adenovirus might be useful for gene therapy, thereby                            
                providing the “motivation” to support the combination relied on by the examiner.                   
                Instead, we agree with appellants (Brief, page 21) that “[w]hen viewed as a                        
                whole, Stratford-Perricauded, at best, provides a general teaching that further                    
                experimentation might at some point establish that adenovirus vectors are useful                   
                in gene therapy applications for treating neurological diseases.”  In this regard,                 
                we remind the examiner that “[a] general incentive does not make obvious a                         
                particular result, nor does the existence of techniques by which those efforts can                 
                be carried out.”  In re Deuel, 51 F.3d 1552, 1559, 34 USPQ2d 1210, 1216 (Fed.                      
                Cir. 1995).  While a “general incentive” may make an approach “obvious to try” it                  
                does not make the invention obvious.  “Obvious to try” is not the standard of                      
                obviousness under 35 U.S.C. § 103.  In re O’Farrell, 853 F.2d 894, 903, 7                          
                USPQ2d 1673, 1680 (Fed. Cir. 1988).                                                                







Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  Next 

Last modified: November 3, 2007